Outlook Therapeutics OTLK
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.58 | -0.38 | -13,484 | -23 | ||
| 2025Q3 | 1.06 | -0.19 | -17,315 | -13 | ||
| 2025Q2 | 1.60 | 78.46 | 2.54 | -0.55 | -15,749 | -20 |
| 2025Q1 | 1.22 | 26.74 | -1.77 | -12,392 | -46 | |
| 2024Q4 | 1.89 | -124.10 | 0.72 | -21,607 | 17 | |
| 2024Q3 | 5.34 | -358.97 | 0.76 | -22,877 | 6 | |
| 2024Q2 | 7.38 | -43.74 | 4.38 | -19,563 | 44 | |
| 2024Q1 | 11.94 | 17.01 | -8.34 | -18,940 | -114 | |
| 2023Q4 | 7.88 | 90.80 | -0.86 | -10,323 | -11 | |
| 2023Q3 | 4.42 | 89.29 | -0.99 | -12,459 | -13 | |
| 2023Q2 | 34.80 | 86.13 | -1.64 | -18,141 | -21 | |
| 2023Q1 | 21.80 | 100.23 | -0.49 | -6,838 | -7 | |
| 2022Q4 | 21.60 | 96.63 | -1.60 | -15,688 | -19 | |
| 2022Q3 | 24.40 | 100.08 | -1.20 | -13,988 | -14 | |
| 2022Q2 | 20.40 | 99.14 | -1.60 | -17,024 | -18 | |
| 2022Q1 | 35.60 | 98.09 | -1.80 | -18,910 | -20 | |
| 2021Q4 | 27.20 | 93.34 | -1.60 | -13,150 | -14 | |
| 2021Q3 | 43.40 | 99.34 | -1.60 | -13,436 | -13 | |
| 2021Q2 | 49.80 | 99.75 | -1.40 | -11,475 | -12 | |
| 2021Q1 | 45.00 | 98.22 | -1.60 | -12,625 | -13 |